$0.5513
-0.0436-7.33%
Last update: Nov 9, 1:35 PM
60 Degrees Pharmaceuticals Inc
SXTPNASDAQ
The average analyst price target for 60 Degrees is $3.70, 571.1% above the current price. Of 2 analysts, 1 rates it Buy and 1 Hold. The latest change came on May 22, 2026, when Ascendiant Capital lowered its price target on 60 Degrees from $4.20 to $3.70 and kept a Buy rating.
Price Target Range — 5 Quarters
Analyst Consensus — 2 Analysts
Rating Trend — Last 9 Months
